Literature DB >> 22588717

Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint.

Stefano Fumagalli1, Vasily V Ivanenkov, Teng Teng, George Thomas.   

Abstract

Impairment of ribosome biogenesis leads to p53 induction and cell cycle arrest, a checkpoint involved in human disease. Induction of p53 is attributed to the binding and inhibition of human double minute 2 (Hdm2) by a subset of ribosomal proteins (RPs): RPS7, RPL5, RPL11, and RPL23. However, we found that only RPL11 or RPL5, in a mutually dependent manner, elicit this response. We show that depletion of RPS7 or RPL23, like depletion of other RPs, except for RPL11 and RPL5, induces a p53 response and that the effects of RPS7 and RPL23 on p53 induction reported earlier may be ascribed to inhibition of global translation. Moreover, we made the surprising observation that codepletion of two essential RPs, one from each subunit, but not the same subunit, leads to suprainduction of p53. This led to the discovery that the previously proposed RPL11-dependent mechanism of p53 induction, thought to be caused by abrogation of 40S biogenesis and continued 60S biogenesis, is still operating, despite abrogation of 60S biogenesis. This response leads to both a G1 block and a novel G2/M block not observed when disrupting either subunit alone. Thus, induction of p53 is mediated by distinct mechanisms, with the data pointing to an essential role for ribosomal subunits beyond translation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22588717      PMCID: PMC3360559          DOI: 10.1101/gad.189951.112

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  51 in total

1.  Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6.

Authors:  S Volarevic; M J Stewart; B Ledermann; F Zilberman; L Terracciano; E Montini; M Grompe; S C Kozma; G Thomas
Journal:  Science       Date:  2000-06-16       Impact factor: 47.728

Review 2.  An encore for ribosome biogenesis in the control of cell proliferation.

Authors:  G Thomas
Journal:  Nat Cell Biol       Date:  2000-05       Impact factor: 28.824

3.  Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome.

Authors:  Andrea Pellagatti; Teresa Marafioti; Jennifer C Paterson; Jillian L Barlow; Lesley F Drynan; Aristoteles Giagounidis; Stefano A Pileri; Mario Cazzola; Andrew N J McKenzie; James S Wainscoat; Jacqueline Boultwood
Journal:  Blood       Date:  2010-04-01       Impact factor: 22.113

Review 4.  The nucleolus: structure/function relationship in RNA metabolism.

Authors:  Danièle Hernandez-Verdun; Pascal Roussel; Marc Thiry; Valentina Sirri; Denis L J Lafontaine
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-09-22       Impact factor: 9.957

5.  An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.

Authors:  Everardo Macias; Aiwen Jin; Chad Deisenroth; Krishna Bhat; Hua Mao; Mikael S Lindström; Yanping Zhang
Journal:  Cancer Cell       Date:  2010-09-14       Impact factor: 31.743

Review 6.  The role of p53 in ribosomopathies.

Authors:  Stefano Fumagalli; George Thomas
Journal:  Semin Hematol       Date:  2011-04       Impact factor: 3.851

7.  Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells.

Authors:  Shilpee Dutt; Anupama Narla; Katherine Lin; Ann Mullally; Nirmalee Abayasekara; Christine Megerdichian; Frederick H Wilson; Treeve Currie; Arati Khanna-Gupta; Nancy Berliner; Jeffery L Kutok; Benjamin L Ebert
Journal:  Blood       Date:  2010-11-10       Impact factor: 22.113

Review 8.  Signaling to p53: ribosomal proteins find their way.

Authors:  Yanping Zhang; Hua Lu
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

9.  Specific activation of the p53 pathway by low dose actinomycin D: a new route to p53 based cyclotherapy.

Authors:  Meng Ling Choong; Henry Yang; May Ann Lee; David P Lane
Journal:  Cell Cycle       Date:  2009-09-13       Impact factor: 4.534

10.  Functional dichotomy of ribosomal proteins during the synthesis of mammalian 40S ribosomal subunits.

Authors:  Marie-Françoise O'Donohue; Valérie Choesmel; Marlène Faubladier; Gwennaële Fichant; Pierre-Emmanuel Gleizes
Journal:  J Cell Biol       Date:  2010-09-06       Impact factor: 10.539

View more
  97 in total

Review 1.  Translational Control during Cellular Senescence.

Authors:  Matthew J Payea; Carlos Anerillas; Ravi Tharakan; Myriam Gorospe
Journal:  Mol Cell Biol       Date:  2021-01-25       Impact factor: 4.272

2.  p53 is positively regulated by miR-542-3p.

Authors:  Yemin Wang; Jen-Wei Huang; Maria Castella; David George Huntsman; Toshiyasu Taniguchi
Journal:  Cancer Res       Date:  2014-04-24       Impact factor: 12.701

3.  The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway.

Authors:  A Bailly; A Perrin; L J Bou Malhab; E Pion; M Larance; M Nagala; P Smith; M-F O'Donohue; P-E Gleizes; J Zomerdijk; A I Lamond; D P Xirodimas
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

4.  Ribosome biogenesis dysfunction leads to p53-mediated apoptosis and goblet cell differentiation of mouse intestinal stem/progenitor cells.

Authors:  A Stedman; S Beck-Cormier; M Le Bouteiller; A Raveux; S Vandormael-Pournin; S Coqueran; V Lejour; L Jarzebowski; F Toledo; S Robine; M Cohen-Tannoudji
Journal:  Cell Death Differ       Date:  2015-06-12       Impact factor: 15.828

5.  Sirtuin 7 plays a role in ribosome biogenesis and protein synthesis.

Authors:  Yuan-Chin Tsai; Todd M Greco; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2013-10-10       Impact factor: 5.911

6.  Balanced production of ribosome components is required for proper G1/S transition in Saccharomyces cerevisiae.

Authors:  Fernando Gómez-Herreros; Olga Rodríguez-Galán; Macarena Morillo-Huesca; Douglas Maya; María Arista-Romero; Jesús de la Cruz; Sebastián Chávez; Mari Cruz Muñoz-Centeno
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

7.  mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.

Authors:  Kaveh M Goudarzi; Monica Nistér; Mikael S Lindström
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

Review 8.  Probing the mechanisms underlying human diseases in making ribosomes.

Authors:  Katherine I Farley; Susan J Baserga
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

Review 9.  Dysregulation of RNA polymerase I transcription during disease.

Authors:  K M Hannan; E Sanij; L I Rothblum; R D Hannan; R B Pearson
Journal:  Biochim Biophys Acta       Date:  2012-11-12

Review 10.  Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.

Authors:  Tiffany Devine; Mu-Shui Dai
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.